In the work report session, the heads of each department took the stage in turn, and comprehensively demonstrated the work highlights, achievements and challenges and opportunities of their respective departments in the past year through detailed data and cases, and reported on the work plan and work objectives for the next year.

Subsequently, Professor Shi Yuanyuan, chairman of the Board, commented on the work of various departments of the company in 2024, and made a comprehensive and in-depth summary of the overall development of the group. He spoke highly of the remarkable achievements made by various departments in the past year, especially the major breakthroughs in scientific research innovation and main business income. Chairman Shi Yuan pointed out that Shenzhen Cell Valley, as a leading one-stop solution provider for cell and gene therapy in China, has always adhered to the original intention of "curing diseases and saving lives" and is committed to promoting the innovation and application of cell therapy technology. In the past year, the company has made significant progress in the research and development of a new gene editing delivery system, and has established close strategic partnerships with a number of authoritative medical institutions in China to jointly promote the vigorous development of the cell and gene therapy industry. At the same time, Chairman Shi Yuan also pointed out the challenges and shortcomings faced by the company in the process of development, and stressed that under the background of the rapid development of the biomedical industry and the increasingly fierce market competition, Shenzhen Cell Valley needs to continuously strengthen its own strength and enhance its core competitiveness.

Looking forward to the future, Chairman Shi Yuan confidently said that Shenzhen Cell Valley will continue to uphold its original intention and continue to work intensively in the CGT field. In 2025, the company will increase investment in scientific research, optimize the talent structure, strengthen team building, and actively seek cooperation and exchanges with other enterprises and institutions. At the same time, Shenzhen Cell Valley will also actively expand overseas markets, enhance brand influence, and gradually realize the sustainable development of the company. Chairman Shi Yuan stressed that Shenzhen Cell Valley will continue to deepen technology research and development, grinding process innovation, with breakthroughs in key links to help the industry leapfrog development, and make greater contributions to the cause of human health.

In 2024, the cell Valley people uphold the original heart, tough forward, and constantly break through themselves. Looking forward to 2025, all employees of Shenzhen Cell Valley will work together with confidence to deepen technological innovation, improve service quality, contribute to the rapid development of Shenzhen Cell Valley, and make positive contributions to the high-quality development of the cell and gene therapy industry!